Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

(2021) Akshay Sharma et al.   Lancet Haematology

Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

(2021) Ayelet Grupper et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients

(2021) Smaragdi Marinaki et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

(2021) Leticia Monin et al.   LANCET ONCOLOGY

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

(2021) William A. Werbel et al.   ANNALS OF INTERNAL MEDICINE

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients

(2021) Rabah Redjoul et al.   LANCET

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

(2021) Per Ljungman et al.   LEUKEMIA

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

(2020) Evan J. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE